MANKIND — Mankind Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual balance sheet for Mankind Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	12,943	15,216	33,865	24,851	22,680
Net Total Accounts Receivable
Net Total Receivables	11,106	12,184	14,497	22,247	17,338
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	44,068	43,279	65,682	69,883	69,542
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	23,896	30,170	31,387	32,140	36,143
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	91,477	97,154	119,633	277,595	280,795
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	26,235	18,631	21,197	56,636	65,073
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	29,925	22,802	26,002	134,271	117,792
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	61,552	74,352	93,631	143,324	163,003
Total Liabilities & Shareholders' Equity	91,477	97,154	119,633	277,595	280,795
Total Common Shares Outstanding